Oct 5 : Amgen has interpretation issuesof the confirmatory study variety, at least according to an FDA advisory committee that voted against converting the accelerated approval of its oral G12C KRAS inhibitor Lumakras (sotorasib) to full approval in non-small cell lung cancer (NSCLC)
In the first clinical trial testing the Novo drug in people with type 1 diabetes and obesity, the 36 patients who received weekly semaglutide injections along with their usual insulin spent more time in their target blood sugar range and lost more weight than 36 similar patients who got a placebo along with their insulin, study leader Dr
Mikitsh JL, Chacko AM
It's more expensive but extremely effective
Discontinuation isn't a failure
Pharma Industry 1 min read Novo Nordisk plans to cut price of Ozempic as generics hit market "The revised price of Novo's Ozempic will be at a 30-50% premium to some large Indian brands that have priced their generic semaglutide at around 4,000," an industry insider told ET, suggesting a price cut to about 5,000-6,000